Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Bacterial reverse mutation assay: WoE approch, result: positive
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- April 16-25, 1996
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- only one strain tested (to reproduce result from previous study), documentation limited
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1983
- Deviations:
- yes
- Remarks:
- only one strain was tested
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his-operon
- Species / strain / cell type:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9-mix, Aroclor 1254 induced
- Test concentrations with justification for top dose:
- 0, 4, 20, 100, 500, 2500 and 5000 µg/plate (1st experiment)
0, 20, 100, 500, 2500, 3750 and 5000 µg/plate (2nd experiment) - Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- not specified
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Remarks:
- a dose-related increase in the number of revertants was observed, but this was only exceeding the critical factor of 2 in the second experiment.
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- The test substance is mutagenic in the bacterial reverse mutation assay.
- Executive summary:
The test item was tested for its mutagenic potential in bacterial cells according to OECD 471 with one Salmonella typhimirium strain (TA 1537). The following doses were tested:
0, 4, 20, 100, 500, 2500 and 5000 µg/plate (1st experiment)
0, 20, 100, 500, 2500, 3750 and 5000 µg/plate (2nd experiment)
the presence of a metabolic activation system a dose-dependent and reproducible increase in the number of revertants was observed with the tester strain TA 1537. In the absence of metabolic activation a dose-related increase in the number of revertants was also observed, but this was only exceeding the critical factor of 2 in the second experiment. However, based on the result of the study, test item is considered to be mutagenic in bacterial cells.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- only 4 bacterial strains tested
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1983
- Deviations:
- no
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9-mix, Aroclor 1254 induced
- Test concentrations with justification for top dose:
- 6 doses from 4 to 5000 µg/plate
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation) (range-finding study (Experiment 1) and main experiment (Experiment 2))
DURATION
- Exposure duration: 48 - 72 h
NUMBER OF REPLICATIONS: triplicates
DETERMINATION OF CYTOTOXICITY
- Method: revertant colony number and microscopical inspection of the bacterial background lawn
The results of both experiments (exp.1 and 2) were used for determining the mutagenic properties of the test substance.- Evaluation criteria:
- A chemical is considered to have a positive response, if it
-produces at least a 2-fold increase in the mean number of revertants per plate of at least one of the tester strains over the mean number of revertants per plate of the appropriate vehicle control at complete bacterial background lawn
-induces a dose-related increase in the mean number of revertants per plate
The results must be reproducible. - Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- In this assay the test substance was considered to be mutagenic.
- Executive summary:
The test item was tested for its mutagenic potential in bacterial cells according to OECD 471 with four Salmonella typhimurium strains (TA 100, TA 1535, TA 1537, TA 98). Six test concentration from 4 – 5000 µg/plate were used. In the presence of a metabolic activation system a dose-dependent and reproducible increase in the number of revertants was observed with the tester strain TA 1537. In the absence of metabolic activation a slight increase was also observed, but only in one strain. Therefore the test item was considered to be mutagenic in bacterial cells.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 5 to 7, 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Principles of method if other than guideline:
- only 4 strains tested
- GLP compliance:
- yes
- Remarks:
- KoreaGLP
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his-operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix
- Test concentrations with justification for top dose:
- experiment I: 0, 8, 40, 200, 1000, 5000 µg/plate
experiment II: 6.9,20.6, 61.7, 185.2, 555.6, 1666.7 µg/plate - Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- sodium azide
- furylfuramide
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) (range-finding study (Experiment 1) and main experiment (Experiment 2))
DURATION
- Exposure duration: 48 - 72 h
NUMBER OF REPLICATIONS: triplicates (experiment I), duplicate (experiment I)
DETERMINATION OF CYTOTOXICITY
- Method: revertant colony number and microscopical inspection of the bacterial background lawn
The results of both experiments (exp.1 and 2) were used for determining the mutagenic properties of the test substance. - Evaluation criteria:
- Results are judged as positive if the number of colony increases with dose-response and reaches 2 times that of the control, or if there is statistically significant increase in the number of colonies in any of the tester strains.
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- In the presence of S9-mix, there was significant increase in the number of revertants in strain TA 1537, which reached up to 8 times that of the control and was reproducible.
- Conclusions:
- The test item was mutagenic in the bacterial reverse mutation assay.
- Executive summary:
The test item was tested for its mutagenic potential in bacterial cells according to OECD 471 with four Salmonella typhimurium strains (TA 100, TA 1535, TA 1537, TA 98). The following doses were tested:
experiment I: 0, 8, 40, 200, 1000, 5000 µg/plate
experiment II: 6.9,20.6, 61.7, 185.2, 555.6, 1666.7 µg/plate
In the presence of S9-mix, there was significant increase in the number of revertants in strain TA 1537, which reached up to 8 times that of the control and was reproducible. Therefore the test item was considered to be mutagenic in bacterial cells.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Genetic toxicity in vivo
Description of key information
The test substance was not clastogenic in the in vivo mammalian erythrocyte micronucleus test (reference 7.6.2-1).
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1st, 1996 to July 18th, 1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1983
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
- Species:
- mouse
- Strain:
- other: SHOE:NMRI
- Details on species / strain selection:
- The mouse is the recommended test species for this assay.
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Tierzucht Schönwalde GmbH i.G., Schönwalde, Germany
- Age at study initiation: appr. 8 weeks
- Weight at study initiation: males mean: 36.8 g, females mean: 29.8 g
- Housing: five animals per cage
- Diet: ad libitum rat/mice diet ssniff (ssniff GmbH, Soest, Germany)
- Water: tap water ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 3
- Humidity (%): 50+/-20
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle/solvent used: sesame oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
On the day of the experiment, the test item was suspended in sesame oil. A magnetic stirrer was used to keep the preparation homogenous until administration. - Duration of treatment / exposure:
- one treatment
- Frequency of treatment:
- one oral gavage treatment
- Post exposure period:
- Animals were killed 12, 24 or 48 h after dosing.
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- Remarks:
- killing times: 12, 24 or 48 h, 5 males and 5 females each
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- killing times: 12, 24 or 48 h, 5 males and 5 females each
- No. of animals per sex per dose:
- 5 per killing time
- Control animals:
- yes
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: oral (gavage)
- Doses / concentrations: 50 mg/kg bw - Tissues and cell types examined:
- erythrocytes
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
prelinimary toxicity study
DETAILS OF SLIDE PREPARATION:
A suspension of bone marow (taken from the femorae) and fetal bovine serum was formed and centrifuged for 5 minutes at app. 1200 rpm. The supernatant was discarded. The sediment was smeared on a clean slide. Staining was performed with Giemsa solution.
METHOD OF ANALYSIS:
1000 polychromatic erythrocytes were counted for each animal. The number of cells with micronuclei was recorded. - Evaluation criteria:
- A substance is considered positive if there is a significant increase in the numbe rof micronucleated polychromatic erythrocytes for at least one of the time points compared with the concurent negative control group.
- Statistics:
- Wilcoxon-test (one-sided)
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- No mortality and no clinical signs of toxicity were observed. No macroscopic findings were recorded at dissection.
- Conclusions:
- The test item was not clastogenic in vivo under the conditions of the present study.
- Executive summary:
The test substance was tested in an in vivo micronucleus test according to OECD Guideline 474. The test item was suspended in sesame oil and administered once via gavage at doses of 0 and 2000 mg/kg bw to male and female NMRI mice. The animals were killed either after 12, 24 or 48 h (5/sex/killing time). Endoxan (cyclophosphamide) was used as positive control at a dose of 50 mg/kg bw. The number of polychromatic and normochromatic erythrocytes containing micronuclei was not increased. The ratio of polychromatic/normochromatic erythrocytes in both male and female animals remained unaffected by the treatment with the test item and was statistically not different from the control values. The positive control induced a marked statistically significant increase in the number of polychromatic cells with micronuclei. The ratio of polychromatic erythrocytes to normocytes was not changes to a significant extent. Under the conditions of the study, th test item is not mutagenic in this test.
Reference
Please refer to the attached background material.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Ames test, reference 7.6.1-1
The test item was tested for its mutagenic potential in bacterial cells according to OECD 471 with four Salmonella typhimurium strains (TA 100, TA 1535, TA 1537, TA 98). Six test concentration from 4 – 5000 µg/plate were used. In the presence of a metabolic activation system a dose-dependent and reproducible increase in the number of revertants was observed with the tester strain TA 1537. In the absence of metabolic activation a slight increase was also observed, but only in one strain. Therefore the test item was considered to be mutagenic in bacterial cells.
Ames test, reference 7.6.1-2
The test item was tested for its mutagenic potential in bacterial cells according to OECD 471 with one Salmonella typhimirium strain (TA 1537). The following doses were tested: 0, 4, 20, 100, 500, 2500 and 5000 µg/plate (1st experiment); 0, 20, 100, 500, 2500, 3750 and 5000 µg/plate (2nd experiment), the presence of a metabolic activation system a dose-dependent and reproducible increase in the number of revertants was observed with the tester strain TA 1537. In the absence of metabolic activation a dose-related increase in the number of revertants was also observed, but this was only exceeding the critical factor of 2 in the second experiment. However, based on the result of the study, test item is considered to be mutagenic in bacterial cells.
Ames test, reference 7.6.1-3
The test item was tested for its mutagenic potential in bacterial cells according to OECD 471 with four Salmonella typhimurium strains (TA 100, TA 1535, TA 1537, TA 98). The following doses were tested: experiment I: 0, 8, 40, 200, 1000, 5000 µg/plate; experiment II: 6.9,20.6, 61.7, 185.2, 555.6, 1666.7 µg/plate. In the presence of S9-mix, there was significant increase in the number of revertants in strain TA 1537, which reached up to 8 times that of the control and was reproducible. Therefore the test item was considered to be mutagenic in bacterial cells.
In vivo-study: Micronucleus assay, reference 7.6.2-1
The test substance was tested in an in vivo micronucleus test according to OECD Guideline 474. The test item was suspended in sesame oil and administered once via gavage at doses of 0 and 2000 mg/kg bw to male and female NMRI mice. The animals were killed either after 12, 24 or 48 h (5/sex/killing time). Endoxan (cyclophosphamide) was used as positive control at a dose of 50 mg/kg bw. The number of polychromatic and normochromatic erythrocytes containing micronuclei was not increased. The ratio of polychromatic/normochromatic erythrocytes in both male and female animals remained unaffected by the treatment with the test item and was statistically not different from the control values. The positive control induced a marked statistically significant increase in the number of polychromatic cells with micronuclei. The ratio of polychromatic erythrocytes to normocytes was not changes to a significant extent. Under the conditions of the study, the test item is not mutagenic in this test.
Based on these results and additionally taking into account a structurally similar substance (1-Naphthalenesulfonic acid, 6-diazo-5,6-dihydro-5-oxo-, 4-benzoyl-1,2,3-benzenetriyl ester, CAS 5610-94-6), a genotoxic potential can be excluded. This substance was tested according to OECD guidelines 471, 473 and 476, and no clastogenic or mutagenic potential was revealed.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. Based on available data on genetic toxicity, the test item is not considered to be classified for genetic toxicity according to Regulation (EC) No 1272/2008 (CLP), as amended for the seventeenth time in Regulation (EU) 2021/849.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.